Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
NeurAxis Logo
NeurAxis Growth Score
62
CB Rank
33184
Heat Score
46
NeurAxis develops neuromodulation therapies to address chronic and debilitating conditions in children.
Founded
obfuscation
PublicPost-IPO Equity Carmel, Indiana, United States11-50 www.neuraxis.com
Health Care
Medical
Therapeutics
Overview

NeurAxis
Total Funding
obfuscation
Growth Score
62
Heat Score
46

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score62
0 pts
in past quarter
Heat Score 46
4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About NeurAxis

CB Rank
33184
NeurAxis develops neuromodulation therapies to address chronic and debilitating conditions in children.
Founded
obfuscation
PublicPost-IPO Equity Carmel, Indiana, United States11-50 www.neuraxis.com
Health Care
Medical
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name NEURAXIS, INC.
Operating Status Active
Stock Symbol  NYSEMKT:NRXS
Company Type For Profit
About the Company

NeurAxis is a healthcare company that provides localized hypothermia for neuroprotection. The company delivers localized hypothermia to the injured or risky tissues during surgery. It takes only 15 minutes to achieve the target temperature in the injured tissue after application and postoperative hypothermia can be delivered easily without

reopening the injury.

Phone Number (812)-689-0791
Contact Email info@neuraxis.com
Predictions & Insights

Growth Insight

See this Growth Insight
NeurAxis is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

IB-Stim
A wearable, non-surgical device cleared by the FDA for treating functional abdominal pain linked to IBS and functional dyspepsia in adolescents aged 8-21.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Flagstaff International Logo
Flagstaff International
Yes
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
Flagstaff International Logo
Flagstaff International
Yes
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
Flagstaff International Logo
Flagstaff International
Yes
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
Flagstaff International Logo
Flagstaff International
Yes
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
Flagstaff International Logo
Flagstaff International
Yes
Post-IPO Equity - NeurAxis Logo
Post-IPO Equity - NeurAxis
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Contacts 11

Employee Profiles

News

News and Press

News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,581
147.42%
 in past month

IT Spend

$243.1KThis year, NeurAxis is projected to spend $243.1K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
ABC News Logo
ABC News
77
Politico Logo
Politico
76
Wellness Benefits Logo
Wellness Benefits
76

Active Website Tech Count

34NeurAxis is actively using 34 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  HSTS.
Sub-Organizations
Frequently Asked Questions

Where is NeurAxis's headquarters? NeurAxis is located in Carmel, Indiana, United States.Who invested in NeurAxis? NeurAxis is funded by Flagstaff International.When was the last funding round for NeurAxis? NeurAxis closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are NeurAxis's competitors? Alternatives and possible competitors to NeurAxis may include Nervonik, Saluda Medical, and  Spark Biomedical.How much funding has NeurAxis raised to date? NeurAxis has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(250d0b0 1)
|